The Pattern of Dry Eye Disease After Cataract Surgery
Ocular Surface and Corneal Morphological Changes After the Cataract Surgery and Associations With Inflammatory Biomarkers
Lithuanian University of Health Sciences
100 participants
Mar 1, 2024
OBSERVATIONAL
Conditions
Summary
This study is designed to explore dry eye disease (DED) pattern: ocular surface, corneal morphological changes, patients' subjective assessment of DED and their correlations with ocular surface inflammation, pain biomarkers after cataract surgery according to ocular surface lubrication with artificial tears during long-term follow-up.
Eligibility
Inclusion Criteria3
- Cataract patients from 50 to 90 years old who underwent uncomplicated phacoemulsification performed by one (and same) experienced surgeon.
- Patients with no underlying ocular surface diseases (keratitis, keratoconjunctivitis and others).
- Patients who previously did not undergo any ophthalmic surgery.
Exclusion Criteria10
- Patient expressed his wish to not participate in the study or discontinue it when already enrolled.
- Severe dry eye disease diagnosed with OSDI/DEQ-5 and at least one of the following tests: TBUT less than 10 seconds, tear osmolarity higher than 308 mOsm/l or positive corneal staining.
- Glaucoma.
- Diabetes mellitus.
- Systemic connective tissue disease, autoimmune disease.
- Neurologic conditions including stroke, Bell's palsy, Parkinson's, trigeminal nerve dysfunction.
- Patients who underwent refractive surgery (LASIK or PRK).
- Contact lens users.
- One or more of the following concomitant medications: psychiatric medicines, antihistamines and/or hormonal replacement.
- Patients who are already regularly using topical drops or ointments.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients randomised into Ist study group will use artificial tears 7 days before the cataract surgery 4 times a day and they will continue to use them after surgery for 3 months.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06298890